CME
by ReachMD
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·385 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 20 epsHost
Recent guests
Recent episodes
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
Jul 14, 2026
13m 15s
Closing the Gaps: Global Implementation of Lipid Guidelines
Jun 30, 2026
1h 00m 00s
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Jun 23, 2026
17m 15s
Unblocking Clinical Inertia: The CMI Era in oHCM Care
Jun 16, 2026
39m 00s
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jun 1, 2026
14m 15s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
Resolving iTunes ID\u2026 if this persists, the podcast may not be indexed on Apple Podcasts.
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/14/26 | chronic kidney diseasediabetes+3 | Brendon Neuen, MBBS, PhDKatherine Tuttle, MD | ERA 2026chronic kidney disease | — | chronic kidney diseaseCKD+3 | — | 13m 15s | ||
| 6/30/26 | lipid guidelinescardiovascular care+3 | Lina Badimón, MD, PhDMichelle O’Donoghue, MD, MPH+6 | CMEReachMD | — | lipid managementcardiovascular risk+3 | — | 1h 00m 00s | ||
| 6/23/26 | nonsteroidal MRAsheart failure+4 | Muthiah Vaduganathan, MD, MPHKoichiro Kinugawa, MD+4 | finerenoneSGLT2 inhibitors+1 | — | nonsteroidal MRAsheart failure+5 | — | 17m 15s | ||
| 6/16/26 | obstructive hypertrophic cardiomyopathyheart failure+3 | Elena ArbeloSilvia Aguiar | Heart Failure Congress 2026 | — | oHCMheart failure+5 | — | 39m 00s | ||
| 6/1/26 | advanced urothelial carcinomaNCCN Guidelines+4 | Jean Hoffman-Censits, MDJean Hoffman-Censits | NCCNCME+1 | — | urothelial carcinomaNCCN Guidelines+6 | — | 14m 15s | ||
| 6/1/26 | HER2 expressionsolid tumors+4 | Kathleen N. Moore, MD, MSKathleen N. Moore | trastuzumab deruxtecan (T-DXd) | — | HER2solid tumors+5 | — | 18m 00s | ||
| 5/29/26 | perioperative immunotherapyhead and neck cancer+4 | Adam J. Luginbuhl, MD | ReachMDCME+2 | — | immunotherapyHNSCC+4 | — | 5m 15s | ||
| 5/29/26 | perioperative immunotherapyhead and neck squamous cell carcinoma+4 | Jennifer Johnson, MD, PhD | ReachMDTurning Evidence Into Action: Applying Perioperative Data to Real-World Practice | — | perioperative dataimmunotherapy+4 | — | 5m 15s | ||
| 5/29/26 | perioperative immunotherapyhead and neck cancer+4 | Adam J. Luginbuhl, MD | ReachMDperioperative immunotherapy | — | immunotherapyHNSCC+5 | — | 4m 45s | ||
| 5/29/26 | immunotherapyperioperative care+3 | Jennifer Johnson, MD, PhD | ReachMDHNSCC | — | immunotherapyHNSCC+5 | — | 5m 30s | ||
| 5/14/26 | biologicsatopic dermatitis+3 | Amy Spizuoco, DO, FAOCDAmy Spizuoco | Practical DermatologyReachMD | — | biologicsatopic dermatitis+3 | — | 0m 45s | ||
| 5/2/26 | obstructive hypertrophic cardiomyopathytreatment transition+4 | Anjali Owens, MD | ReachMDcardiac myosin inhibitors+2 | — | oHCMtreatment selection+6 | — | 10m 46s | ||
| 4/30/26 | iron deficiencyCKD+3 | Brendon Neuen, MBBS, PhD | KDIGOChronic Kidney Disease | — | iron deficiencyCKD+5 | — | 11m 30s | ||
| 4/10/26 | retinal diseasesinjection therapies+4 | Deepak Sambhara, MDDeepak Sambhara | The Focused Sight InitiativeCME | — | retinal diseasesage-related macular degeneration+5 | — | 57m 45s | ||
| 4/7/26 | pediatric nephrologyC3 glomerulopathy+3 | Richard Lafayette, MD, FACPAnkana Daga, MD | C3 glomerulopathynephrology+1 | — | C3 glomerulopathynephrology+5 | — | 14m 15s | ||
| 3/31/26 | antihistaminesCKD-associated pruritus+3 | Antoine Lanot, MD, PhDGil Yosipovitch, MD | CMEReachMD | — | CKDantihistamines+5 | — | 16m 00s | ||
| 3/31/26 | head and neck cancerimmune checkpoint inhibition+3 | Ravindra Uppaluri, MD, PhDNancy Lee, MD, FASTRO | KEYNOTE-689NIVOPOSTOP+2 | — | HNSCCimmune checkpoint inhibition+5 | — | 15m 30s | ||
| 3/31/26 | KIT-targeted tyrosine kinase inhibitorsindolent systemic mastocytosis+4 | Mariana C. Castells, MD, PhDTsewang Tashi, MD | avapritinibelenestinib+2 | — | KIT inhibitorstyrosine kinase inhibitors+6 | — | 14m 15s | ||
| 3/26/26 | mineralocorticoid receptor antagonismheart failure+5 | Maria Pabon, MDRobert J. Mentz, MD, FHFSA, FACC | ReachMD | — | mineralocorticoid receptor antagonismheart failure+5 | — | 15m 00s | ||
| 3/26/26 | obstructive hypertrophic cardiomyopathyprecision-based therapy+3 | Michael Nassif, MD, MScMichael Nassif | ReachMDcardiac myosin inhibitors+2 | — | oHCMtreatment+5 | — | 4m 30s |
Showing 20 of 20
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.